10.12 USD
+0.05 (+0.5%)
10.12 USD
0 (0%)
DCTH gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. While DCTH has a great health rating, its profitability is only average at the moment. DCTH is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
In the past year DCTH was profitable.
DCTH had a positive operating cash flow in the past year.
In the past 5 years DCTH always reported negative net income.
DCTH had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
DCTH's Return On Assets of 0.96% is fine compared to the rest of the industry. DCTH outperforms 73.91% of its industry peers.
Looking at the Return On Equity, with a value of 1.04%, DCTH is in the better half of the industry, outperforming 73.91% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 4.00%, DCTH is in the better half of the industry, outperforming 73.37% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.96% | ||
| ROE | 1.04% | ||
| ROIC | 4% |
ROA(3y)-120.78%
ROA(5y)-101.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DCTH's Profit Margin of 1.50% is fine compared to the rest of the industry. DCTH outperforms 74.46% of its industry peers.
DCTH has a Operating Margin of 7.39%. This is in the better half of the industry: DCTH outperforms 73.37% of its industry peers.
Looking at the Gross Margin, with a value of 86.29%, DCTH belongs to the top of the industry, outperforming 95.11% of the companies in the same industry.
In the last couple of years the Gross Margin of DCTH has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.39% | ||
| PM (TTM) | 1.5% | ||
| GM | 86.29% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.01%
GM growth 5Y8.9%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DCTH is destroying value.
Compared to 1 year ago, DCTH has more shares outstanding
Compared to 5 years ago, DCTH has more shares outstanding
DCTH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 18.53 indicates that DCTH is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 18.53, DCTH belongs to the top of the industry, outperforming 94.57% of the companies in the same industry.
DCTH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 18.53 |
ROIC/WACC0.45
WACC8.96%
2.3 Liquidity
DCTH has a Current Ratio of 15.06. This indicates that DCTH is financially healthy and has no problem in meeting its short term obligations.
DCTH's Current ratio of 15.06 is amongst the best of the industry. DCTH outperforms 98.37% of its industry peers.
DCTH has a Quick Ratio of 13.71. This indicates that DCTH is financially healthy and has no problem in meeting its short term obligations.
DCTH has a Quick ratio of 13.71. This is amongst the best in the industry. DCTH outperforms 98.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 15.06 | ||
| Quick Ratio | 13.71 |
3. Growth
3.1 Past
DCTH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.74%, which is quite impressive.
Looking at the last year, DCTH shows a very strong growth in Revenue. The Revenue has grown by 251.54%.
Measured over the past years, DCTH shows a very strong growth in Revenue. The Revenue has been growing by 88.10% on average per year.
EPS 1Y (TTM)100.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
Revenue 1Y (TTM)251.54%
Revenue growth 3Y118.63%
Revenue growth 5Y88.1%
Sales Q2Q%83.6%
3.2 Future
The Earnings Per Share is expected to grow by 30.41% on average over the next years. This is a very strong growth
Based on estimates for the next years, DCTH will show a very strong growth in Revenue. The Revenue will grow by 43.08% on average per year.
EPS Next Y104.16%
EPS Next 2Y54.49%
EPS Next 3Y40.62%
EPS Next 5Y30.41%
Revenue Next Year135.81%
Revenue Next 2Y80.94%
Revenue Next 3Y62.34%
Revenue Next 5Y43.08%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 1012.00, DCTH can be considered very expensive at the moment.
64.13% of the companies in the same industry are more expensive than DCTH, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.50, DCTH is valued quite expensively.
A Price/Forward Earnings ratio of 26.69 indicates a quite expensive valuation of DCTH.
73.91% of the companies in the same industry are more expensive than DCTH, based on the Price/Forward Earnings ratio.
DCTH's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.93.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 1012 | ||
| Fwd PE | 26.69 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DCTH is valued a bit cheaper than 69.57% of the companies in the same industry.
DCTH's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DCTH is cheaper than 78.80% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.69 | ||
| EV/EBITDA | 36.12 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
DCTH's earnings are expected to grow with 40.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)9.72
PEG (5Y)N/A
EPS Next 2Y54.49%
EPS Next 3Y40.62%
5. Dividend
5.1 Amount
DCTH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
10.12
+0.05 (+0.5%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners51.08%
Inst Owner Change-1.9%
Ins Owners2.74%
Ins Owner Change0.48%
Market Cap357.34M
Revenue(TTM)79.60M
Net Income(TTM)1.20M
Analysts84.62
Price Target23.61 (133.3%)
Short Float %12.62%
Short Ratio4.53
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)86.27%
Min EPS beat(2)-1.96%
Max EPS beat(2)174.51%
EPS beat(4)2
Avg EPS beat(4)-54.93%
Min EPS beat(4)-488.34%
Max EPS beat(4)174.51%
EPS beat(8)5
Avg EPS beat(8)-13.29%
EPS beat(12)5
Avg EPS beat(12)-23.68%
EPS beat(16)7
Avg EPS beat(16)-17.29%
Revenue beat(2)1
Avg Revenue beat(2)0.07%
Min Revenue beat(2)-3.57%
Max Revenue beat(2)3.72%
Revenue beat(4)3
Avg Revenue beat(4)5.71%
Min Revenue beat(4)-3.57%
Max Revenue beat(4)15.26%
Revenue beat(8)6
Avg Revenue beat(8)14%
Revenue beat(12)6
Avg Revenue beat(12)0.03%
Revenue beat(16)10
Avg Revenue beat(16)26.29%
PT rev (1m)-4.14%
PT rev (3m)-8.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-265.52%
EPS NY rev (1m)7.7%
EPS NY rev (3m)566.74%
Revenue NQ rev (1m)-0.52%
Revenue NQ rev (3m)-25.24%
Revenue NY rev (1m)-1.33%
Revenue NY rev (3m)-10.51%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 1012 | ||
| Fwd PE | 26.69 | ||
| P/S | 4.49 | ||
| P/FCF | 29.69 | ||
| P/OCF | 26.94 | ||
| P/B | 3.11 | ||
| P/tB | 3.11 | ||
| EV/EBITDA | 36.12 |
EPS(TTM)0.01
EY0.1%
EPS(NY)0.38
Fwd EY3.75%
FCF(TTM)0.34
FCFY3.37%
OCF(TTM)0.38
OCFY3.71%
SpS2.25
BVpS3.25
TBVpS3.25
PEG (NY)9.72
PEG (5Y)N/A
Graham Number0.86
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.96% | ||
| ROE | 1.04% | ||
| ROCE | 5.06% | ||
| ROIC | 4% | ||
| ROICexc | 16.98% | ||
| ROICexgc | 16.98% | ||
| OM | 7.39% | ||
| PM (TTM) | 1.5% | ||
| GM | 86.29% | ||
| FCFM | 15.12% |
ROA(3y)-120.78%
ROA(5y)-101.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.01%
GM growth 5Y8.9%
F-Score7
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 625.51% | ||
| Cap/Sales | 1.54% | ||
| Interest Coverage | 6.95 | ||
| Cash Conversion | 218.16% | ||
| Profit Quality | 1004.67% | ||
| Current Ratio | 15.06 | ||
| Quick Ratio | 13.71 | ||
| Altman-Z | 18.53 |
F-Score7
WACC8.96%
ROIC/WACC0.45
Cap/Depr(3y)208.01%
Cap/Depr(5y)235.23%
Cap/Sales(3y)4.01%
Cap/Sales(5y)12.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
EPS Next Y104.16%
EPS Next 2Y54.49%
EPS Next 3Y40.62%
EPS Next 5Y30.41%
Revenue 1Y (TTM)251.54%
Revenue growth 3Y118.63%
Revenue growth 5Y88.1%
Sales Q2Q%83.6%
Revenue Next Year135.81%
Revenue Next 2Y80.94%
Revenue Next 3Y62.34%
Revenue Next 5Y43.08%
EBIT growth 1Y121.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year242.65%
EBIT Next 3Y71.85%
EBIT Next 5YN/A
FCF growth 1Y139.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y143.58%
OCF growth 3YN/A
OCF growth 5YN/A
DELCATH SYSTEMS INC / DCTH FAQ
What is the ChartMill fundamental rating of DELCATH SYSTEMS INC (DCTH) stock?
ChartMill assigns a fundamental rating of 6 / 10 to DCTH.
What is the valuation status for DCTH stock?
ChartMill assigns a valuation rating of 4 / 10 to DELCATH SYSTEMS INC (DCTH). This can be considered as Fairly Valued.
What is the profitability of DCTH stock?
DELCATH SYSTEMS INC (DCTH) has a profitability rating of 4 / 10.
Can you provide the financial health for DCTH stock?
The financial health rating of DELCATH SYSTEMS INC (DCTH) is 8 / 10.
What is the expected EPS growth for DELCATH SYSTEMS INC (DCTH) stock?
The Earnings per Share (EPS) of DELCATH SYSTEMS INC (DCTH) is expected to grow by 104.16% in the next year.